Skip to main content

NVS Competitors

profileAnalyst coverage5 yr. financialspremium researchdividendsadv. chartsearningsoptionsprice historyeventsinsiders

Novartis AG News

Novartis Follows Eli Lilly with $1.4 Billion Gene Editing Pact

Precision BioSciences is developing gene editing tools with several potential advantages over CRISPR.

Novartis and Roche Have Expensive Drugs That Scare Away Competitors

A brief snapshot of some medical breakthroughs that are among the costliest in the world.

5 Top Stock Gainers for Thursday Amid Central Bank Policy Calls

Stocks were mixed Thursday as investors digested policy decisions made by the U.S. Federal Reserve and the Bank of England.

Emergent BioSolutions Begins Phase 1 Trial for Universal Flu Vaccine

Emergent says its flu-vaccine candidate 'contains multiple components to induce broad, supra-seasonal immunity against influenza A viruses.'

Buyback Bonanza: Novartis May Snap Up $15 Billion of Stock

Swiss drug giant Novartis NVS said it plans to deploy up to $15 billion for share buybacks, thanks to its $21 billion sale of Roche shares.

Breaking News

Robinhood Stock Surges, Then Halted, Amid Reports of FTX Takeover Interest

Sam Bankman-Fried's FTX is looking for a path to buy online brokerage group Robinhood, Bloomberg reported Monday.

General Electric Stock Gains As CEO Larry Culp Takes Over Aviation Division

"There is tremendous opportunity in aviation over the coming years, and the Board and I decided it is the right time for me to take on this expanded role," said GE CEO Larry Culp.

Feds Could Stop Trump SPAC Deal

An investigation by a federal grand jury could halt the proposed SPAC deal with Trump's social media company.

McDonald's Brings Back a Classic Menu Item (with a Catch)

You never know what the fast-food chain might bring back or create a new version of.